期刊文献+

IL-19在炎症性疾病中的作用机制与研究进展 被引量:2

Mechanisms and advances of IL-19 in inflammatory diseases
下载PDF
导出
摘要 白细胞介素-19(Interleukin-19,IL-19)是近年来新发现的白细胞介素-10(IL-10)超家族的细胞因子。IL-10普遍被认为是系统性抑制炎症的细胞因子,而IL-19与IL-10序列和结构相似,因此过去认为二者具有相似的生物学活性,但随后有许多研究证明,IL-19的生物学作用与IL-10有诸多不同,并且IL-19在不同系统的疾病中尤其是炎症反应方面也具有不同作用。国内外学者就IL-19在部分炎症性疾病中的发病机制、作为潜在治疗靶点的可行性做了不少研究,现就近年来IL-19在心血管、呼吸等系统炎症性疾病中的作用机制及其研究进展做一综述。 Interleukin-19(IL-19)is a newly discovered cytokine of the interleukin-10(IL-10)superfamily.IL-10 is generally considered to be a systemic cytokine that inhibits inflammation,whereas IL-19 is similar to IL-10's sequence and structure,so it's been thought that both have similar biological activities,but many studies have shown that the biological effects of IL-19 are different from those of IL-10,and IL-19 also has different effects in different systems of diseases,especially in inflammatory response.Researchers have done a lot of research on the pathogenesis of IL-19 in some inflammatory diseases and feasibility of being apotential therapeutic target.The main goal of this review is to discuss the underlying mechanisms and research progress in cardiovascular,respiratory and other inflammatory diseases.
作者 王锟琨 万春 文富强 WANG Kunkun;reviewing;WAN Chun;WEN Fuqiang(West China School of Medicine, Sichuan University, Chengdu 610041, China;Department of Respiratory, West China Hospital, Sichuan University, Chengdu 610041, China)
出处 《西部医学》 2018年第7期1079-1081,1087,共4页 Medical Journal of West China
基金 四川大学青年教师科研启动基金(2015SCU11999-10) 四川省大学生创新创业训练计划项目(201710611785)
关键词 白细胞介素-19 炎症性疾病 作用机制 Interleukin-19 Inflammatory disease Mechanism
  • 相关文献

参考文献4

二级参考文献61

  • 1井申荣,邹全明.白细胞介素10的研究进展[J].免疫学杂志,2006,22(z1):26-28. 被引量:16
  • 2夏熙双.早期颅脑损伤患者血清IL-1β、IL-6、IL-13的变化及意义[J].山东医药,2006,46(18):66-67. 被引量:2
  • 3孔炜,汪晓莺.支气管哮喘患儿外周血白细胞介素19水平及其临床意义[J].南京医科大学学报(自然科学版),2007,27(5):499-501. 被引量:7
  • 4Kodama M, Matsumoto Y, Fujiwara M, et al. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction [J]. Clin Immunol Immunopathol, 1990, 57(2):250-262.
  • 5Kodama M, Matsumoto Y, Fujiwara M, et al. In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis [J]. Circulation, 1992, 85(5): 1918-1926.
  • 6Gallagher G, Dickensheets H, Eskdale J, et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human inteAeukin-lO (ILl0) [J]. Genes, Immnnol, 2000, 1(7): 442-450.
  • 7Dumoutier L, Leemans C, Lejeune D, et al. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL20 receptor complexes of two types [J]. J Immunol, 2001, 167(7):3545-3549.
  • 8Liu W, Feng W, Wang F, et al. Adenovirus-mediated ICOSIg gene transfer alleviates cardiac remodeling in experimental autoimmune myoearditis [J]. Immunol Cell Biol. 2008. 86(8): 659-665.
  • 9Oral HB, Kotenko SV, Yilmaz M, et aL Regulation of T cells and cytokines by the interleukin-lO (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26 [J]. Eur J Immunol, 2006, 36(2):380-388.
  • 10Azuma YT, Matsuo Y, Kuwamura M, et al. Interleukin-19 protects mice from innate-mediated colonic infammation [J]. Infamm Bowel Dis, 2010, 16(6):1017-1028.

共引文献11

同被引文献20

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部